Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mereo Makes Senior Appointments

This article was originally published in Scrip

Executive Summary

Recently-formed biopharmaceutical company Mereo BioPharma Group Ltd. has appointed new members to its senior management and board. Paul Blackburn has been appointed non-executive board director and chair of the audit and risk committee; he joins Mereo from GlaxoSmithKline (GSK), where he was finance controller for almost 40 years. Anthony Hall has been appointed head of orphan diseases and previously was group medical director in the neuromuscular disease area at BioMarin. Jacqueline Parkin has been appointed Mereo's head of respiratory and endocrinology and joins the company from GSK where she held various senior clinical development roles for the past 13 years. Fiona Bor has been appointed head of intellectual property for Mereo and was previously vice president and global head of IP at Mylan Pharmaceuticals. Mereo has also appointed Ian Hodgson head of clinical operations; prior to this he was associate director, clinical operations and EMEA regional oncology lead at Takeda Oncology Company. In addition to these appointments, Stewart Jones has been appointed head of CMC, Craig Manchip head of QA and Julian Lord financial controller.



Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts